Live·Open questions in longevity research
All news
Longevity research

Researchers propose a framework for testing the roles of immune proteins cGAS and STING in aging

21 November 2026· 261121009

Researchers propose a framework for testing the roles of immune proteins cGAS and STING in aging

On November 18, researchers Sebastian Mesa and Paola Murgas published a review of aging research comparing experiments involving these proteins, which help initiate inflammation. In some experiments, inhibiting STING improved the health of old mice; in others, its absence was associated with brain damage.

During aging, a cell's own DNA can escape from damaged nuclei and mitochondria into the cytosol. The DNA sensor cGAS recognizes accessible DNA and can produce cGAMP, a messenger molecule that activates STING, which in turn triggers inflammatory signaling. This mechanism helps defend against infections. A continuous supply of the cell's own DNA can sustain chronic inflammation, providing the rationale for inhibiting this pathway during aging.

In a 2023 study, the STING inhibitor H-151 reduced inflammation in old mice and improved memory, grip strength, and endurance. In the same study, old mice that had lacked STING since birth also had lower levels of some measures of inflammation. Another group found blood-brain barrier damage, microhemorrhages, and movement impairments in aging mice lacking STING. The researchers linked this protective role of STING to microglia, the brain's immune cells, which clear cellular debris and support the surrounding tissue.

Removing a protein affects several of its functions at once. In mouse cells, cGAS helps keep DNA regions containing LINE-1 tightly packed. LINE-1 sequences can make copies of themselves. In experiments involving the loss of cGAS, this packaging was disrupted, DNA copies of LINE-1 accumulated in the cytosol, and inflammation increased. The study authors' model proposes that other cellular sensors respond to these copies. When cGAMP production was blocked without removing cGAS, this increase in LINE-1 activity was not observed.

The authors' DALT framework proposes considering together the age at which an intervention begins and its duration, the amounts of available DNA and cGAMP, the location of these molecules, and cell type and state. They suggest comparing several signal levels and measuring the response at each. A cGAMP molecule can enter a neighboring cell and activate STING there. The response also depends on cell state: microglia can support tissue or release signals that damage it. These conditions are interconnected: the location of DNA determines which enzymes can degrade it and how much remains available for detection.

To test the role of timing, the authors propose switching off the gene encoding STING specifically in mouse microglia late in adulthood. The outcome should be compared with the effects of lifelong STING absence and drug treatment in genetically comparable animals. The authors hypothesize that switching off the gene later in life will produce effects closer to those of the drug than to those of lifelong protein loss. If switching it off later causes the same damage as STING absence from birth, researchers will need to reassess the role of timing, compare which cells each intervention affected, and check for drug side effects. Measurements of inflammation, blood-brain barrier integrity, and behavior would help assess whether damaging signals were suppressed and tissue support was preserved.

Originally published on Telegram by Ukhvat NewsView on Telegram
Sources
#cgas-sting#inflammaging#microglia#cGAMP#line-1#dalt-framework